首页 | 本学科首页   官方微博 | 高级检索  
     

头颈鳞状细胞癌患者血清Cyfra21-1检测的临床意义
引用本文:徐先发,谭静. 头颈鳞状细胞癌患者血清Cyfra21-1检测的临床意义[J]. 中国耳鼻咽喉头颈外科, 2011, 18(9): 457-460
作者姓名:徐先发  谭静
作者单位:1. 北京民航总医院耳鼻喉科;2. 首都医科大学附属北京朝阳医院耳鼻喉科;
摘    要:
目的 探讨血清Cyfra21-1在头颈鳞状细胞癌(head and neck squamous cell carcinoma,HNSCC)中的临床意义.方法 采用双抗体夹心ELISA法对随机选取的60例HNSCC患者,40例甲状腺良性肿瘤患者,20名健康对照组进行血清Cyfra2l-1检测.应用SPSS 11.5统计软...

关 键 词:头颈部肿瘤   癌,鳞状细胞   角蛋白质类   酶联免疫吸附测定   
收稿时间:2008-11-25

Clinical significance of Cyfra21-1 in patients with squamous cell carcinoma of the head and neck
XU Xianfa,TAN Jing. Clinical significance of Cyfra21-1 in patients with squamous cell carcinoma of the head and neck[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2011, 18(9): 457-460
Authors:XU Xianfa  TAN Jing
Affiliation:XU Xianfa1,TAN Jing2(1 Department of Otolaryngology Head and Neck Surgery,Civil Aviation General Hospital,Beijing,100123,China,2 Department of Otolaryngology,West Campus of Beijing Chaoyang Hospital,Capital Medical University,100020,China)
Abstract:
OBJECTIVE To evaluate the clinical significance of Cyfra 21-1 in patients with head and neck squamous cell carcinoma(HNSCC).METHODS Before and after treatment,the serum concentration of Cyfra 21-1 was measured by ELISA assay in 60 patients with HNSCC,40 patients with benign tumors of the thyroid.Also 20 healthy adults were included in this reseach as controls.Statistical analysis was performed using SPSS11.5 statistical package.RESULTSSerum levels of Cyfra21-1 were(6.49±2.90)ng/ml in preoperative patients with HNSCC,(3.39±1.45)ng/ml in postoperative patients with HNSCC,(2.01±0.83)ng/ml in preoperative patients with benign tumors of the thyroid,(1.98±0.85)ng/ml in postoperative patients with benign tumors of the thyroid and(1.90±0.69)ng/ml in control group,respectively.Serum levels of Cyfra21-1 in preoperative patients with HNSCC were significantly higher than those of benign tumors of the thyroid(t=4.69,P0.01)and healthy controls(t=5.74,P0.01).There was no significant difference in the concentration of serum Cyfra21-1 between the patients with benign tumors of the thyroid and the healthy controls(t=1.21,P0.05).After operation,levels of Cyfra21-1 in HNSCC decreased significantly(t=3.57,P0.01),but it didn't displayed significant difference in benign tumors of the thyroid(t=1.92,P0.05).The serum concentrations of Cyfra 21-1 in preoperative patients with HNSCC were statistically correlated with the T-stage of the disease(t=2.35,P0.05)and nodal status(t=3.16,P0.01),but not related to the patient age(t=1.81,P0.05)or gender(t=1.32,P0.05).In 4 patients with local tumor recurrence during follow-up,serum Cyfra21-1 levels showed a significant increase compared with the levels after surgery.At the cutoff value of 3.69 ng/ml,the diagnostic sensitivity and specificity of Cyfra 21-1 for HNSCC were 80.0% and 91.7%,respectively.CONCLUSION CYFRA 21-1 can be used as an useful tumor marker of HNSCC in diagnosis,evaluation of therapeutic effect,monitoring of tumor recurrence and the prognosis.
Keywords:Head and Neck Neoplasms  Carcinoma  Squamous Cell  Keratins  Enzyme-Linked Immunosorbent Assay  
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国耳鼻咽喉头颈外科》浏览原始摘要信息
点击此处可从《中国耳鼻咽喉头颈外科》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号